Associated Papers
White-Sutton Syndrome: Insight of an Italian Cohort of 19 Subjects.
Facchini A et al.
Clinical Genetics, 2026
Case Report: White-Sutton syndrome and cannabidiol, an update on a reported patient with a successful response to off--label therapy.
Perilli L et al.
Frontiers in Pediatrics, 2025
White-Sutton syndrome and congenital heart disease: case report and literature review.
Duan J et al.
Bmc Pediatrics, 2023
37016333 (PubMed )
Supplement: 12887_2023_3972_MOESM1_ESM.xlsx › Sheet1
Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring.
Nagy D et al.
Genes, 2022
35052493 (PubMed )
Supplement: genes-13-00154-s001.zip › SUPPLEMENTARY_TABLE_REVISED.xlsx › B_detailed_literature
Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature.
Murch O et al.
European Journal of Human Genetics : Ejhg, 2022
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders.
Wang T et al.
Nature Communications, 2020
33004838 (PubMed )
Supplement: 41467_2020_18723_MOESM10_ESM.xlsx › Supplementary_Data_8
Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes.
Matsumura K et al.
Nature Communications, 2020
Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome).
Assia Batzir N et al.
American Journal of Medical Genetics. Part A, 2020
POGZ-related epilepsy: Case report and review of the literature.
Ferretti A et al.
American Journal of Medical Genetics. Part A, 2019
POGZ truncating alleles cause syndromic intellectual disability.
White J et al.
Genome Medicine, 2016
Select a paper to view details